Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Egetis Therapeutics Major Shareholding Notification 2024

Oct 31, 2024

3152_iss_2024-10-31_d478c42b-9b30-4f59-ba11-2867bee4d911.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

Cetoros AB

Instrument

Instrument Aktie SE0003815604
Before the transaction
Shares 33,776,221
Voting rights 33,776,221
Transaction
Reason for major shareholding notification New share issue
Date 31/10/2024
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 33,776,221
Directly held voting rights 33,776,221
Indirectly held voting rights 0
Percentage
Directly held shares 9.4022 %
Directly held voting rights 9.4022 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 9.4022 % 33,776,221
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 9.4022 % 33,776,221
Group
total
holdings
Voting rights
33,776,221
Percentage of voting rights 9.4022
Published
31/10/2024 04:09
Contact
Name
Peder Walberg
Phone
0703797556
Email [email protected]
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25